FDA Approves the First Drug for Alzheimer’s Agitation: Rexulti
As many as half of people who develop Alzheimer’s dementia experience the symptom of agitation, which can lead to behaviors like pacing, restlessness, and…
As many as half of people who develop Alzheimer’s dementia experience the symptom of agitation, which can lead to behaviors like pacing, restlessness, and…
According to a leading neurology researcher, getting at least 10,000 steps per day can decrease your chance of getting Alzheimer’s by as much as…
It may be possible to spot a telling combination of three specific dementia warning signs up to 9 years before a dementia diagnosis, according…
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer’s. Following this a bumpy road for another Alzheimer’s drug candidate that could supplant…
With a new FDA approval, the Alzheimer’s drug found in Aricept will soon be on the market in skin patch form called Adlarity. The…
Image: Aduhelm, Biogen/AP. “The approach I’ve been taking is that each decision about whether or not to offer this as a treatment has to…
Due to apparent “deficiencies” in trial data, the FDA has rejected a request to approve Acadia Pharmaceutical’s application for the repurposing of Parkinson’s drug…